Intraoperative tranexamic acid to decrease blood loss during myomectomy: a randomized, double-blind, placebo-controlled trial

Published:March 27, 2020DOI:


      Myomectomy is associated with a significant risk of hemorrhage. Tranexamic acid is a synthetic lysine derivative with antifibrinolytic activity used in other surgical disciplines to reduce blood loss during surgery. However, its utility in gynecologic surgery is not well understood.


      This study aimed to determine the effect of early administration of intravenous tranexamic acid on perioperative bleeding and blood transfusion requirements in women undergoing myomectomy.

      Study Design

      This study was a double-blinded, randomized, placebo-controlled trial conducted in an academic teaching hospital. Women with symptomatic fibroids thought to be at risk for large intraoperative blood loss who met the following criteria were included in the study: (1) at least 1 fibroid ≥10 cm, (2) any intramural or broad ligament fibroid ≥6 cm, and/or (3) at least 5 total fibroids based on preoperative imaging. Patients were randomized to receive a single intravenous bolus injection of tranexamic acid 15 mg/kg (intervention group) versus an intravenous bolus injection of saline of equivalent volume (placebo group) 20 minutes before the initial surgical incision. Perioperative bleeding was defined by measuring intraoperative estimated blood loss, change between pre- and postoperative hemoglobin, and frequency of blood transfusions. Estimated blood loss was calculated by combining the blood volume collected within the suction canister and the weight of used sponges. The 2 groups were compared for age; body mass index; perioperative hemoglobin and hematocrit; perioperative blood loss; duration of surgery; blood transfusion requirements; and the number, total weight, and volume of myomas removed.


      A total of 60 patients (30 per arm) were enrolled into the study between March 1, 2015, and January 29, 2018. Age, body mass index, baseline hemoglobin and/or hematocrit, number and total weight of myomas removed, and size of myomas did not differ between arms. Of 60 patients, 32 (53%) had laparoscopic myomectomy, 24 (40%) had robotic myomectomy, and 4 (7%) had laparotomy. Median estimated blood loss was 200 mL for the tranexamic acid group and 240 mL for the placebo group (P=.88). There was no difference in median duration of surgery (165 vs 164 minutes; P=.64) or change in perioperative hemoglobin (1.00 vs 1.1 g/dL; P=.64). Patients in the tranexamic acid group did not require blood transfusions; however, 4 patients (13.3%) in the placebo group (P=.11) required blood transfusions.


      Intravenous administration of tranexamic acid in patients undergoing laparoscopic or robotic myomectomies was not associated with decreased blood loss.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Baird D.D.
        • Dunson D.B.
        • Hill M.C.
        • Cousins D.
        • Schectman J.M.
        High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.
        Am J Obstet Gynecol. 2003; 188: 100-107
        • Stewart E.A.
        Uterine fibroids.
        Lancet. 2001; 357: 293-298
        • LaMorte A.I.
        • Lalwani S.
        • Diamond M.P.
        Morbidity associated with abdominal myomectomy.
        Obstet Gynecol. 1993; 82: 897-900
        • Saccardi C.
        • Gizzo S.
        • Noventa M.
        • Ancona E.
        • Borghero A.
        • Litta P.S.
        Limits and complications of laparoscopic myomectomy: which are the best predictors? A large cohort single-center experience.
        Arch Gynecol Obstet. 2014; 290: 951-956
        • Sinha R.
        • Hegde A.
        • Mahajan C.
        • Dubey N.
        • Sundaram M.
        Laparoscopic myomectomy: do size, number, and location of myomas form limiting factors for laparoscopic myomectomy?.
        J Minim Invasive Gynecol. 2008; 15: 292-300
        • Kongnyuy E.J.
        • Wiysonge C.S.
        Interventions to reduce hemorrhage during myomectomy for fibroids.
        Cochrane Database Syst Rev. 2014; 8: CD005355
        • Wellington K.
        • Wagstaff A.J.
        Tranexamic acid: a review of its use in the management of menorrhagia.
        Drugs. 2003; 63: 1417-1433
        • Henry D.A.
        • Carless P.A.
        • Moxey A.J.
        • et al.
        Anti-fibrinolytic use for minimizing perioperative allogeneic blood transfusion.
        Cochrane Database Syst Rev. 2011; 3: CD001886
        • Topsoee M.F.
        • Bergholt T.
        • Ravn P.
        • et al.
        Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy—a double-blinded randomized placebo-controlled trial.
        Am J Obstet Gynecol. 2016; 215: 72.e1-72.e8
        • Caglar G.S.
        • Tasci Y.
        • Kayikcioglu F.
        • Haberal A.
        Intravenous tranexamic acid use in myomectomy: a prospective randomized double-blind placebo controlled study.
        Eur J Obstet Gynecol Reprod Biol. 2008; 137: 227-231
        • Shaaban M.M.
        • Ahmed M.R.
        • Farhan R.E.
        • Dardeer H.H.
        Efficacy of tranexamic acid on myomectomy-associated blood loss in patients with multiple myomas: a randomized controlled clinical trial.
        Reprod Sci. 2016; 23: 908-912
        • Ngichabe S.
        • Obura T.
        • Stones W.
        Intravenous tranexamic acid as an adjunct haemostat to ornipressin during open myomectomy: a randomized double blind placebo controlled trial.
        Ann Surg Innov Res. 2015; 9: 10
        • Bennasr L.
        • Marzouk S.B.
        • Ajili S.
        • et al.
        Effect of the addition of tranexamic acid on the prevention of bleeding during abdominal myomectomy: a randomized prospective study.
        Ann Fr Anesth Reanim. 2014; 33: 724
        • Schulz K.F.
        • Altman D.G.
        • Moher D.
        • CONSORT Group
        CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.
        BMC Med. 2010; 8: 18
        • Goswami U.
        • Sarangi S.
        • Gupta S.
        • Babbar S.
        Comparative evaluation of two doses of tranexamic acid used prophylactically in anemic parturients for lower segment cesarean section: a double-blind randomized case control prospective trial.
        Saudi J Anaesth. 2013; 7: 427-431
        • Vargas M.V.
        • Moawad G.N.
        • Sievers C.
        • et al.
        Feasibility, safety, and prediction of complications for minimally invasive myomectomy in women with large and numerous myomata.
        J Minim Invasive Gynecol. 2017; 24: 315-322
        • Gargiulo A.R.
        • Srouji S.S.
        • Missmer S.A.
        • Correia K.F.
        • Vellinga T.
        • Einarsson J.I.
        Robot-assisted laparoscopic myomectomy compared with standard laparoscopic myomectomy.
        Obstet Gynecol. 2012; 120: 284-291
        • Sinha R.
        • Hegde A.
        • Warty N.
        • Mahajan C.
        Laparoscopic myomectomy: enucleation of the myoma by morcellation while it is attached to the uterus.
        J Minim Invasive Gynecol. 2005; 12: 284-289
        • Zhao F.
        • Jiao Y.
        • Guo Z.
        • Hou R.
        • Wang M.
        Evaluation of loop ligation of larger myoma pseudocapsule combined with vasopressin on laparoscopic myomectomy.
        Fertil Steril. 2011; 95: 762-766